Sohm(OTC) SHMN

SOHM, Inc. is a healthcare company focused on developing, manufacturing, marketing, and distributing generic and private label pharmaceutical products in the United States. The company offers a diverse range of products, including analgesics, antibiotics, and nutraceuticals, while also engaging in genome editing collaborations.

Products and Services

• Generic and private label pharmaceutical products
• Analgesics, antibiotics, and anti-inflammatory drugs
• Cosmeceuticals and nutraceuticals

Growth Outlook

• Collaboration with Coastar Therapeutics enhances innovation potential
• Expanding product portfolio to meet market demands
• Focus on increasing export opportunities in international markets

Financial Highlights

• Recent quarterly revenue of $75,013, showing potential for growth
• Trailing twelve months (TTM) gross profit margin at 78.12%
• Current ratio of 1.15 indicates adequate short-term financial health

SOHM, Inc. operates in the medical and pharmaceutical industry, providing essential healthcare products. The company's recent collaboration with Coastar Therapeutics positions it well for future advancements in genome editing, which could lead to innovative product offerings. The diverse product range, including over-the-counter medications and nutraceuticals, caters to a broad customer base, enhancing market reach. Financially, the company has shown resilience with a gross profit margin of 78.12% over the trailing twelve months, indicating effective cost management and pricing strategies. The recent quarterly revenue of $75,013 reflects ongoing operations, while the current ratio of 1.15 suggests that SOHM, Inc. maintains a healthy balance between its current assets and liabilities, ensuring it can meet short-term obligations. Overall, SOHM, Inc. presents a compelling opportunity for investors interested in the pharmaceutical sector, particularly those looking for companies with innovative growth potential and a diverse product portfolio.